Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04188587 | 177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer | unknown | Phase 2 | 30 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Dec 6, 2019 | clinicaltrials |
| NCT04180592 | Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate. | unknown | N/A | 20 | Queen's UniversityOTHER | 1 | Dec 4, 2019 | clinicaltrials |
| NCT04182594 |
| Cardiovascular Events in GnRH Agonist vs. Antagonist |
| unknown |
| Phase 2 |
| 80 |
| Rabin Medical CenterOTHER |
| 1 |
| Dec 2, 2019 |
| clinicaltrials |
| NCT03786848 | Personalized Mini-PDX for Metastatic CRPC | unknown | N/A | 15 | Tianjin Medical University Second HospitalOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT03021200 | Laser Fluorescence in Cancer Surgical Treatment | unknown | N/A | 270 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04159051 | Charité HT-Prostate | unknown | N/A | 100 | Charite University, Berlin, GermanyOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04159090 | Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard | unknown | N/A | 20 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04158414 | Applying PET/MR in Oncology - a Prospective Project | unknown | N/A | 500 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 8, 2019 | clinicaltrials |
| NCT04154280 | Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer | unknown | N/A | 50 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04148885 | A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 44 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Nov 4, 2019 | clinicaltrials |
| NCT03572946 | Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection | unknown | N/A | 400 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 14, 2019 | clinicaltrials |
| NCT04124107 | Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection | unknown | N/A | 50 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Oct 14, 2019 | clinicaltrials |
| NCT04113096 | Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer | unknown | Early Phase 1 | 104 | The University of The West IndiesOTHER | 1 | Oct 8, 2019 | clinicaltrials |
| NCT04116086 | Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage | unknown | N/A | 50 | Sheba Medical CenterOTHER_GOV | 1 | Oct 4, 2019 | clinicaltrials |
| NCT02799303 | MRI Versus PSA in Prostate Cancer Screening(MVP) | unknown | N/A | 1,010 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT04110782 | Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)(RaProRad) | unknown | — | 400 | Azienda Policlinico Umberto IOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT04108871 | Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men | unknown | N/A | 180 | The University of Hong KongOTHER | 1 | Sep 30, 2019 | clinicaltrials |
| NCT04107142 | Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour | unknown | Phase 1 | 10 | CytoMed Therapeutics Pte LtdINDUSTRY | 1 | Sep 27, 2019 | clinicaltrials |
| NCT03679819 | Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer(EXACTVU) | unknown | — | 50 | Institut Paoli-CalmettesOTHER | 1 | Sep 26, 2019 | clinicaltrials |
| NCT04101305 | Measurement of Circulating Tumor Cells in Prostate Cancer(ICELLATEPC) | unknown | — | 40 | Sormland County Council, SwedenOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT04050397 | Exercise and Quality of Life During Androgen Deprivation Therapy | unknown | N/A | 40 | Tampere University HospitalOTHER | 1 | Sep 11, 2019 | clinicaltrials |
| NCT03600766 | Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study | unknown | Phase 2 | 50 | Mansoura UniversityOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT02759783 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases(CORE) | unknown | Phase 2 / Phase 3 | 245 | Royal Marsden NHS Foundation TrustOTHER | 2 | Aug 21, 2019 | clinicaltrials |
| NCT01682772 | TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer(TOPARP) | unknown | Phase 2 | 148 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT02292914 | Prospective Analysis of Robot-Assisted Surgery | unknown | N/A | 1,120 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT03451812 | Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer(PCAPETMR) | unknown | — | 120 | Chang Gung Memorial HospitalOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT02873013 | Asia Study Group of Prostate Cancer (A-CaP Study) | unknown | — | 20,000 | Japan Study Group of Prostate CancerOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT03587285 | A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer | unknown | Phase 1 / Phase 2 | 11 | Guangzhou University of Traditional Chinese MedicineOTHER | 1 | Aug 1, 2019 | clinicaltrials |
| NCT04037488 | Changes in Body Composition With Patients Under Androgen Deprivation Therapy | unknown | — | 56 | Seoul National University HospitalOTHER | 1 | Jul 30, 2019 | clinicaltrials |
| NCT02225262 | A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | unknown | N/A | 100 | Community Cancer Center, Normal, IllinoisOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT04031378 | Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer | unknown | Phase 2 | 100 | Fundacao ChampalimaudOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT02334579 | Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | unknown | N/A | 146 | Swedish Medical CenterOTHER | 1 | Jul 12, 2019 | clinicaltrials |
| NCT04004858 | Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT)(PROTRACT) | unknown | N/A | 50 | Southlake HealthOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT03255135 | Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. | unknown | N/A | 130 | Hospital de Transplante Doutor Euryclides de Jesus ZerbiniOTHER | 1 | Jun 27, 2019 | clinicaltrials |
| NCT03996993 | Defining Recurrent Disease With Axumin™ | unknown | — | 20 | Cancer Center of IrvineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT03987737 | Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate(GAS) | unknown | N/A | 46 | Universitaire Ziekenhuizen KU LeuvenOTHER | 0 | Jun 17, 2019 | clinicaltrials |
| NCT03982706 | Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy | unknown | — | 1,000 | Rabin Medical CenterOTHER | 0 | Jun 13, 2019 | clinicaltrials |
| NCT03980587 | Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum Treatment(EMIT) | unknown | — | 18 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 10, 2019 | clinicaltrials |
| NCT03979573 | Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer(PROMM-AS) | unknown | N/A | 90 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jun 7, 2019 | clinicaltrials |
| NCT03960788 | Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer | unknown | Early Phase 1 | 50 | University of CincinnatiOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT00906269 | Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer(HBOT) | unknown | Phase 4 | 100 | Hartford HospitalOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT01311856 | Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors | unknown | — | 60 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00850941 | Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | unknown | — | 146 | M.D. Anderson Cancer CenterOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT00573586 | Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada | unknown | N/A | 20 | SonaCare MedicalINDUSTRY | 1 | May 3, 2019 | clinicaltrials |
| NCT03630926 | Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.(VPAC) | unknown | — | 45 | Intermountain Health Care, Inc.OTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT02861209 | Collaborative Network to Take Responsibility for Oral Anticancer Therapy(CONTACT) | unknown | N/A | 228 | KU LeuvenOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT00770822 | Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer(SetPace) | unknown | N/A | 466 | SonaCare MedicalINDUSTRY | 1 | Apr 10, 2019 | clinicaltrials |
| NCT00772317 | A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)(STAR) | unknown | N/A | 117 | SonaCare MedicalINDUSTRY | 2 | Apr 10, 2019 | clinicaltrials |
| NCT02040610 | Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer | unknown | N/A | 235 | Provision Center for Proton TherapyOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT03880851 | MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)(Mbase_HyPro) | unknown | N/A | 78 | University Hospital TuebingenOTHER | 1 | Mar 20, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Dec 6, 2019source: clinicaltrials